ASO Author Reflections: Neoadjuvant Therapy as a Selection Strategy for Curative Resection in High-Risk Intrahepatic
Yawen Dong1,2, Patrick Starlinger3
1Department of Surgery, Division of Hepatobiliary and Pancreas Surgery, Mayo Clinic, Rochester, MN, USA. dong.yawen@mayo.edu.
Annals of Surgical Oncology
|May 4, 2026
Abstract
No abstract available in PubMed .


